78 results

• Zantac Cancer Risks Concealed By GlaxoSmithKline for Decades, Whistleblower Lawsuit Alleges

  May 21, 2024

  Irvin Jackson

  A whistleblower lawsuit against GlaxoSmithKline claims the company violated state and federal false claims laws by concealing the presence of NDMA, a cancer causing chemical, in the heartburn drug Zantac, which was later removed from the market and reformulated with a different active ingredient.

• Whistleblower Lawsuit Over Suboxone Kickback Scheme Allowed to Proceed by Judge

  October 27, 2023

  Irvin Jackson

  A federal judge has cleared the way for a Suboxone whistleblower lawsuit to proceed, claiming the manufacturers engaged in a kickback scheme which led to Medicare paying more for the opioid addiction drug than necessary.

• Philips Respironics Settlement Results in $24.8M Payment To Resolve Kickback Claims

  September 13, 2022

  Irvin Jackson

  The DOJ has reached a settlement agreement requiring Philips Respironics to pay more than $24 million to resolve illegal kickback allegations.

• Bayer Whistleblower Settlement Over Trasylol, Avelox and Baycol Results in $40 Million Payment

  September 7, 2022

  Irvin Jackson

  Bayer has agreed to pay $40 million to resolve a whistleblower lawsuit which accused it of kickback schemes and off-label marketing of the drugs Avelox, Baycol and Trasylol.

• Whistleblower Warned of Similac Manufacturing Problems in February 2021, CNN Reports

  June 10, 2022

  Irvin Jackson

  A former Abbott employee says the company knew about manufacturing problems at the plant a year before a recall was announced following infant illnesses and deaths.

• Gilead Must Face Whistleblower Lawsuit Over Alleged Sovaldi and Harvoni Kickback Scheme

  April 6, 2022

  Irvin Jackson

  A whistleblower lawsuit against Gilead can proceed with allegations the company was engaged in illegal Solvaldi and Harvoni kickback schemes.

• Acthar Settlement Results in $260M Payment to Resolve DOJ Fraud and Illegal Kickback Allegations

  March 9, 2022

  Irvin Jackson

  Mallinckrodt will pay $260 million to resolve illegal Medicaid fraud and kickback claims brought against it by whistleblowers and the federal government over its marketing of Acthar gel.

• NHTSA Whistleblower Settlement Results In $24M Payment For Uncovering Kia, Hyundai Safety Violations

  November 10, 2021

  Russell Maas

  The NHTSA has handed out its first whistleblower compensation to an employee who revealed safety violations by Hyundai and Kia, leading to millions of vehicles being recalled due to engine fire risks.

• SEC Whistleblower Settlements Have Resulted in $1 Billion in Awards Paid For Uncovering Violations of Securities Laws

  September 20, 2021

  Russell Maas

  Whistleblower claims hit a $1 billion landmark this month in money rewarded to those who uncover fraud against the government.

• St. Jude Settles Justice Dept Charges Over ICD Battery Problems With $27M Payment

  July 20, 2021

  Irvin Jackson

  St. Jude will pay the Justice Department $27 million to settle a whistleblower claim that it lied to the FDA about the safety of several of its implantable defibrillators, which resulted in patient deaths and a recall.